• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vimian Group

30.30 SEK

-0.98 %

Less than 1K followers

VIMIAN

NASDAQ Stockholm

Health Care Providers

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.98 %
+0.66 %
+11.89 %
-0.13 %
+3.77 %
-25.04 %
-0.66 %
-
-61.32 %

Vimian Group is a group operating in animal health. The company, through its subsidiaries, delivers pharmaceuticals and technical solutions to veterinarians, laboratories and pet owners. The products include, for example, pharmaceuticals with associated clinical research and digital platforms for veterinary clinics. The company operates on a global level with headquarters in Stockholm.

Read more
Market cap
16.04B SEK
Turnover
735.93K SEK
Revenue
4.59B
EBIT %
15.72 %
P/E
46.75
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17/7
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

11/2
2027

Annual report '26

Press release2 hours ago

Subscription period for Vimian’s incentive program 2023-2026 has commenced

Vimian Group
Press release2 hours ago

Teckningsperioden avseende Vimians incitamentsprogram 2023-2026 har inletts

Vimian Group
Regulatory press release4/29/2026, 2:00 PM

Press release from the Annual General Meeting in Vimian Group AB (publ) on 29 April 2026

Vimian Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/29/2026, 2:00 PM

Kommuniké från årsstämman i Vimian Group AB (publ) den 29 april 2026

Vimian Group
Vimian Group, Audiocast, Q1'26
Webcast4/29/2026, 7:00 AM

Vimian Group, Audiocast, Q1'26

Vimian Group
Regulatory press release4/29/2026, 5:45 AM

Vimian’s Interim Report for the first quarter of 2026

Vimian Group
Regulatory press release4/29/2026, 5:45 AM

Vimians delårsrapport för det första kvartalet 2026

Vimian Group
Press release4/21/2026, 8:10 AM

Invitation to Vimian’s Interim Report for the first quarter of 2026

Vimian Group
Press release4/21/2026, 8:10 AM

Inbjudan till Vimians delårsrapport för det första kvartalet 2026

Vimian Group
Regulatory press release3/19/2026, 6:45 AM

Notice of Annual General Meeting in Vimian Group AB (publ)

Vimian Group
Regulatory press release3/19/2026, 6:45 AM

Kallelse till årsstämma i Vimian Group AB (publ)

Vimian Group
Regulatory press release3/19/2026, 6:30 AM

Vimian publishes Annual Report and Sustainability Report for 2025

Vimian Group
Regulatory press release3/19/2026, 6:30 AM

Vimian publicerar Års- och Hållbarhetsredovisning för 2025

Vimian Group
Regulatory press release3/13/2026, 7:00 AM

Vimian Group AB (publ) appoints Lotta Lundaas Head of Medtech and member of the Vimian Group management team

Vimian Group
Regulatory press release3/13/2026, 7:00 AM

Vimian Group AB (publ) utser Lotta Lundaas till Head of MedTech och medlem av Vimians koncernledning

Vimian Group
Vimian Year-end report interview!3:07
Video2/12/2026, 9:24 AM

Vimian Year-end report interview!

Vimian Group’s new CEO, Alireza Tajbakhsh, is being interviewed after the Q4 report today.

Vimian Group
Vimian Group, Audiocast, Q4'25
Webcast2/12/2026, 8:00 AM

Vimian Group, Audiocast, Q4'25

Vimian Group
Regulatory press release2/12/2026, 6:45 AM

Vimian’s year-end report for 2025

Vimian Group
Regulatory press release2/12/2026, 6:45 AM

Vimians bokslutskommuniké för 2025

Vimian Group
Press release2/2/2026, 9:00 AM

Invitation to Vimian’s year-end report for 2025

Vimian Group